This conference brings together researchers using quantitative approaches to advance the understanding and application of biology at the molecular level.  These approaches are contributing to the development of analytical, diagnostic, and therapeutic strategies that are directly relevant to public health. The meeting will also stimulate efforts to integrate these approaches across the molecular, cellular, and higher scales of biological complexity in a single-track Gordon-style conference format that includes hotel accomodations and most meals. 

Keynote Speakers:

• Jay Keasling, Chief Executive, Joint BioEnergy Institute, University of California, Berkeley. "Synthetic Biology in Pursuit of Low-Cost, Effective, Anti-Malarial Drugs."
• Peter Schultz, Scripps Professor of Chemistry, The Scripps Institute, and Institute Director of the Genomics Institute of the Novartis Research Foundation. "An Expanding Genetic Code."
• James Wells, Harry William and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences,  University of California, San Francisco. "Engineering Cells to Death"

You can view our general program here or our detailed program with abstracts at the Session Snooper. 

If you were not able to attend the first conference, in 2007, you can buy a CD of the proceedings.  Simply fax this PDF to us at 646-495-1507 or mail it to SBE, 3 Park Ave, 19th floor, New York, NY 10016. 

Registration will close on Jan. 16. Register now!